Literature DB >> 35347560

Current Treatment Options for Cutaneous Adnexal Malignancies.

Hiroyuki Goto1.   

Abstract

OPINION STATEMENT: Cutaneous adnexal malignancies include various types of malignant tumors that show differentiation of cutaneous appendages. They can be classified into sweat gland, hair follicle, and sebaceous gland differentiations. All types of cutaneous adnexal tumors are rare and standard treatment options based on valid evidence have not been established. Although prognosis differs depending on the type of cutaneous adnexal malignancy, surgery is the mainstay of treatment. In surgical treatment, an adequate surgical margin is unclear for wide local excision. Mohs micrographic is a better option than wide local excision in terms of margin control and cosmetic outcome because the face, head, and neck are favorable sites for some cutaneous adnexal malignancies. There has been no randomized trial of radiation therapy and chemotherapy for any cutaneous adnexal malignancies. Radiation therapy should be considered if the tumor cannot be removed surgically. Chemotherapy is one of the options for metastatic cases in some types of cutaneous adnexal malignancies, but evidence of the effectiveness of chemotherapy is lacking. Recent studies have revealed genetic mutations in this field, and target therapy and immunotherapy may be promising treatment options for unresectable cutaneous adnexal malignancies in the future.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Chemotherapy; Cutaneous adnexal malignancy; Metastasis; Radiation therapy; Surgery

Mesh:

Year:  2022        PMID: 35347560     DOI: 10.1007/s11864-022-00971-3

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  89 in total

Review 1.  Eccrine porocarcinoma: a report of 2 cases and review of the literature.

Authors:  Anson Nguyen; Anh V Nguyen
Journal:  Cutis       Date:  2014-01

Review 2.  Chemotherapy of rare skin adnexal tumors: a review of literature.

Authors:  Francesca De Iuliis; Lucrezia Amoroso; Ludovica Taglieri; Stefania Vendittozzi; Luciana Blasi; Gerardo Salerno; Rosina Lanza; Susanna Scarpa
Journal:  Anticancer Res       Date:  2014-10       Impact factor: 2.480

3.  Factors in the surgical management of primary eccrine porocarcinoma: prognostic histological factors can guide the surgical procedure.

Authors:  E Belin; K Ezzedine; S Stanislas; N Lalanne; M Beylot-Barry; A Taieb; B Vergier; T Jouary
Journal:  Br J Dermatol       Date:  2011-09-20       Impact factor: 9.302

4.  A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas.

Authors:  Dora Dias-Santagata; Quynh Lam; Kristin Bergethon; Gabrielle M Baker; A John Iafrate; Dinesh Rakheja; Mai P Hoang
Journal:  Mod Pathol       Date:  2011-03-18       Impact factor: 7.842

5.  Treatment of eccrine porocarcinoma with metastasis to the parotid gland using intensity-modulated radiation therapy: a case report.

Authors:  Youssef H Zeidan; A Jason Zauls; Masha Bilic; Eric J Lentsch; Anand K Sharma
Journal:  J Med Case Rep       Date:  2010-05-22

Review 6.  Eccrine porocarcinoma.

Authors:  Clarence William Brown; Lady Christine Dy
Journal:  Dermatol Ther       Date:  2008 Nov-Dec       Impact factor: 2.851

Review 7.  Treatment of Malignant Cutaneous Adnexal Neoplasms.

Authors:  C Bernárdez; L Requena
Journal:  Actas Dermosifiliogr (Engl Ed)       Date:  2017-10-06

Review 8.  Eccrine Porocarcinoma: New Insights and a Systematic Review of the Literature.

Authors:  Azadeh Nazemi; Shauna Higgins; Reyna Swift; Gino In; Kimberly Miller; Ashley Wysong
Journal:  Dermatol Surg       Date:  2018-10       Impact factor: 3.398

9.  Sentinel lymph node biopsy in porocarcinoma: A case reports.

Authors:  Simona Reina; Denise Palombo; Alexandru Boscaneanu; Nicola Solari; Sergio Bertoglio; Luca Valle; Ferdinando Cafiero
Journal:  Int J Surg Case Rep       Date:  2018-10-31

10.  Eccrine Porocarcinoma: A Challenging Diagnostic and Therapeutic Tumoral Entity.

Authors:  Ha Mo Linh Le; Laurence Faugeras; Véronique De Moor; Caroline Fervaille; Thierry Vander Borght; Fanny Collette; Lionel D'Hondt
Journal:  Case Rep Oncol       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.